⌘K

Login Start Free

Home/Filings/4/0001104659-23-036043

4//SEC Filing

Saik Andrew 4

Accession 0001104659-23-036043

CIK 0001270073other

View on SEC.gov Company Profile

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 4:01 PM ET

Size

4.9 KB

Accession

0001104659-23-036043

Insider Transaction Report

Form 4

Period: 2023-03-21

INTERCEPT PHARMACEUTICALS, INC.ICPT

EVP & Chief Financial Officer

Transactions

Tax Payment
Common Stock
2023-03-21$14.19/sh−909$12,899→ 70,081 total

Footnotes (1)

[F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file

4
tm2310362-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1

filerCIK 0001616284

Filing Metadata

Form type: 4
Filed: Mar 22, 8:00 PM ET
Accepted: Mar 23, 4:01 PM ET
Size: 4.9 KB

View on SEC.gov